These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 12673167

  • 1. Intra-arterial radionuclide therapy for liver tumours: effect of selectivity of catheterization and 131I-Lipiodol delivery on tumour uptake and response.
    Brans B, Bacher K, Vandevyver V, Vanlangenhove P, Smeets P, Thierens H, Dierckx RA, Defreyne L.
    Nucl Med Commun; 2003 Apr; 24(4):391-6. PubMed ID: 12673167
    [Abstract] [Full Text] [Related]

  • 2. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
    Brans B, De Winter F, Defreyne L, Troisi R, Vanlangenhove P, Van Vlierberghe H, Lambert B, Praet M, de Hemptinne B, Dierckx RA.
    Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
    [Abstract] [Full Text] [Related]

  • 3. 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma.
    Toubeau M, Touzery C, Berriolo-Riedinger A, Cochet A, Brunotte F, Bedenne L, Cercueil JP, Krause D.
    Eur J Nucl Med; 2001 May; 28(5):669-70. PubMed ID: 11383874
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selective radionuclide localisation in primary liver tumours (pilot study).
    Novell JR, Green AJ, Hilson AJ, Dusheiko G, Dick R, Hobbs KE.
    HPB Surg; 1994 May; 7(3):185-99; discussion 200. PubMed ID: 8155585
    [Abstract] [Full Text] [Related]

  • 6. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol.
    Raoul JL, Messner M, Boucher E, Bretagne JF, Campion JP, Boudjema K.
    Br J Surg; 2003 Nov; 90(11):1379-83. PubMed ID: 14598418
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates.
    Keng GH, Sundram FX, Yu SW, Somanesan S, Premaraj J, Oon CJ, Kwok R, Htoo MM.
    Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301
    [Abstract] [Full Text] [Related]

  • 10. Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up.
    Boucher E, Bouguen G, Garin E, Guillygomarch A, Boudjema K, Raoul JL.
    J Nucl Med; 2008 Mar; 49(3):362-6. PubMed ID: 18287267
    [Abstract] [Full Text] [Related]

  • 11. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
    Raoul JL, Guyader D, Bretagne JF, Heautot JF, Duvauferrier R, Bourguet P, Bekhechi D, Deugnier YM, Gosselin M.
    Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
    [Abstract] [Full Text] [Related]

  • 12. Thyroid uptake and radiation dose after (131)I-lipiodol treatment: is thyroid blocking by potassium iodide necessary?
    Bacher K, Brans B, Monsieurs M, De Winter F, Dierckx RA, Thierens H.
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1311-6. PubMed ID: 12271412
    [Abstract] [Full Text] [Related]

  • 13. Patient dosimetry for 131I-lipiodol therapy.
    Monsieurs MA, Bacher K, Brans B, Vral A, De Ridder L, Dierckx RA, Thierens HM.
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):554-61. PubMed ID: 12690415
    [Abstract] [Full Text] [Related]

  • 14. Safe radiation exposure of medical personnel by using simple methods of radioprotection while administering 131I-lipiodol therapy for hepatocellular carcinoma.
    Garin E, Laffont S, Rolland Y, Olivie D, Lecloirec J, Herry JY, Boucher E, Raoul JL, Bourguet P.
    Nucl Med Commun; 2003 Jun; 24(6):671-8. PubMed ID: 12766603
    [Abstract] [Full Text] [Related]

  • 15. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol (Br J Surg 2003; 90: 1379-1383).
    Rai R, Rai S.
    Br J Surg; 2004 Mar; 91(3):373; author reply 373. PubMed ID: 14991642
    [No Abstract] [Full Text] [Related]

  • 16. Biodistribution and in vivo kinetics of iodine-131 lipiodol infused via the hepatic artery of patients with hepatic cancer.
    Nakajo M, Kobayashi H, Shimabukuro K, Shirono K, Sakata H, Taguchi M, Uchiyama N, Sonoda T, Shinohara S.
    J Nucl Med; 1988 Jun; 29(6):1066-77. PubMed ID: 2836573
    [Abstract] [Full Text] [Related]

  • 17. Biodistribution of lipiodol following hepatic arterial injection.
    Hind RE, Loizidou M, Fleming J, Batty V, Birch S, Taylor I.
    Eur J Surg Oncol; 1992 Apr; 18(2):162-7. PubMed ID: 1316290
    [Abstract] [Full Text] [Related]

  • 18. [How I treat... An hepatocellular carcinoma: role of selective internal radiation therapy with intra-arterial iodine-131].
    Werenne X.
    Rev Med Liege; 2007 Oct; 62(10):603-6. PubMed ID: 18069570
    [Abstract] [Full Text] [Related]

  • 19. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
    De Ruyck K, Lambert B, Bacher K, Gemmel F, De Vos F, Vral A, de Ridder L, Dierckx RA, Thierens H.
    J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
    [Abstract] [Full Text] [Related]

  • 20. Effect of a 188 Re-SSS lipiodol/131I-lipiodol mixture, 188 Re-SSS lipiodol alone or 131I-lipiodol alone on the survival of rats with hepatocellular carcinoma.
    Garin E, Rakotonirina H, Lejeune F, Denizot B, Roux J, Noiret N, Mesbah H, Herry JY, Bourguet P, Lejeune JJ.
    Nucl Med Commun; 2006 Apr; 27(4):363-9. PubMed ID: 16531923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.